ContributorsPublishersAdvertisers

ImmPACT Bio reels in $111M to prevent tumor escape with novel cell therapies

MedCity News
 2022-01-20

Cover picture for the articleCell therapies zero in on cancer cells, but tumors can still find ways to evade such targeted approaches. ImmPACT Bio’s cell therapies are designed to prevent tumor escape and the clinical-stage biotech has raised $111 million to advance their development. The Series B round of financing announced Thursday...

medcitynews.com

Comments / 0

Comments / 0